芦荟色酮的高速逆流色谱分离制备方法研究

芦荟色酮是在芦荟叶中特有的一类具有抗炎和抑制酪氨酸酶等作用的活性物质。以芦荟全叶为原料,经过一系列的预处理手段,从脱色剂活性炭中获得芦荟色酮粗提物,再经过溶剂分配和富集后采用高速逆流色谱（HSCCC）对其中的色酮成分进行分离纯化。研究结果表明,采用氯仿-甲醇-水(体积比为4∶3∶2)混合溶液和二氯甲烷-甲醇-水(体积比为5∶4∶2)混合溶液作为溶剂分离系统,经过两步HSCCC可以分离纯化出色谱纯度在95％以上的芦荟色酮单体。经过紫外检测、快原子轰击质谱及核磁共振等方法的结构分析鉴定,证实分离所得物质为肉桂酰基-C-葡萄糖甙芦荟色酮。     

卷烟主流烟气中8种羰基化合物的超高效液相色谱测定

建立了超高效液相色谱(UPLC）对卷烟主流烟气总粒相物中甲醛、乙醛、丙酮、巴豆醛等8种羰基化合物的测定方法。采用经2,4-二硝基苯肼酸性溶液处理过的剑桥滤片捕集烟气,再用含2%(体积分数）吡啶的乙腈溶液进行萃取,以KinetexTM C18(150 mm×2.1 mm,2.6 μm）为色谱柱,水-乙腈(35∶65）和水-乙腈-四氢呋喃-异丙醇(59∶30∶10∶1）为流动相梯度洗脱,采用二极管阵列检测器进行检测,分析时间为20 min。结果表明,该方法的相关系数r2≥0.999 97,检出限为25.81~67.74 ng/cig,平均加标回收率为95%~99%,相对标准偏差为1.4%~5.8%。各组分峰分离度高、分析时间短、流动相耗量少、结果准确可靠。用该方法对20种不同卷烟牌号样品中8种羰基化合物的含量进行测定,结果满意。     

高效液相色谱法测定柑橘汁中的柠檬苦素和柚皮苷

柑橘汁的苦味主要是由于柚皮苷和柠檬苦素的存在所致,其含量的测定可用于控制柑橘类果汁的质量。采用高效液相色谱法在KR100-5C18(4.6 mm i.d.×250 mm,5 μm)上,分别以乙腈-四氢呋喃-水(体积比为17.5∶17.5∶65)和甲醇-冰醋酸-水(体积比为40∶1∶59)为流动相（流速均为1 mL/min）,在207 nm和283 nm检测波长下分别测定了柠檬苦素和柚皮苷。实验结果表明,柠檬苦素在1.00～50.00 mg/L时线性关系良好(r=0.9992),检出限为0.07 μg,平均加标回收率为98.69%,相对标准偏差（RSD）为2.5%;柚皮苷在20.00～160.00 mg/L时线性关系良好(r=0.9988),检出限为0.14 μg,平均加标回收率为100.13%,RSD为1.5%。用该法检测柑橘汁样品中的柠檬苦素与柚皮苷,方法简便、快速、准确。     

超高效液相色谱–串联质谱法同时测定化妆品中7种双酚类化合物及其衍生物

建立同时快速测定化妆品中7种双酚类化合物及其衍生物的超高效液相色谱–串联质谱方法.水剂化妆品采用正己烷–乙酸乙酯(体积比为1:1)溶液超声提取;粉类、膏霜乳液类、凝胶类化妆品采用乙酸乙酯超声提取,提取液经氮吹浓缩后用甲醇–水(体积比为1:1)溶液定容,用Waters XSelect HSS T3(100 mm×2.1μ...     

高效液相色谱法测定聚丙烯腈基碳纤维原丝中的二甲基亚砜残留

建立了聚丙烯腈（PAN）基碳纤维原丝中二甲基亚砜（DMSO）残留量的高效液相色谱（HPLC）检测方法。采用的色谱柱为Phenomenex C18柱（150 mm×4.6 mm,5 μm）,流动相为甲醇-三氟乙酸-水（体积比为29∶1∶70）混合溶液,流速为1.0 mL/min,进样量为10 μL,检测波长为205 nm,柱温为常温。研究结果表明,在DMSO的质量浓度为1.00~100.00 mg/L范围内,峰面积与质量浓度的线性关系良好,相关系数r=0.9989,最低检出限为0.3 mg/L,平均回收率为98.4%,相对标准偏差（RSD）为2.6%。该方法简便、快速、准确。另外,利用建立的HPLC方法,对原丝中残留的DMSO在水中的溶出规律也进行了研究。     

金属硫蛋白的色谱/电喷雾电离质谱联用表征方法

通过反相液相色谱(RPLC)与电喷雾电离质谱(ESI-MS)的联用技术,对镉诱导金属硫蛋白标准物质MT-1和MT-2的结构进行表征分析。采用Vydac C8 反相色谱柱(250 mm×2.1 mm i.d., 5 μm, 30 nm),流动相A为pH 6.0的5 mmol/L乙酸铵水溶液,流动相B为pH 6.0的5 mmol/L乙酸铵的甲醇-水(体积比为1∶1)溶液,流动相流速为0.20 mL/min,在40 min内流动相B的体积分数从10%增加到37.5%进行梯度洗脱。分别用紫外(UV)和ESI-M     

超高效液相色谱-串联质谱法测定植物源性食品中丁氟螨酯及其代谢物的残留量

建立了超高效液相色谱-串联质谱法（UHPLC-MS/MS）测定水果、蔬菜、茶叶等植物源性食品中丁氟螨酯及其代谢物邻三氟甲基苯甲酸含量的方法。在样品4 g（茶叶1 g）中加入90%（体积分数）乙腈溶液10 mL、1 mol·L^-1盐酸溶液1.0 mL、无水硫酸钠3 g和氯化钠2 g,振荡提取2 min后,离心,取上层乙腈相注入石墨化碳黑固相萃取小柱中净化,再用6 mL体积比为2∶3的丙酮-甲醇的混合液洗脱,收集流出液和洗脱液,于40℃氮吹至近干,加入2 mL 40%（体积分数）乙腈溶液,过滤,取滤液进行UHPLC-MS/MS测定。以Waters ACQUITY UPLC BEH C₁₈柱为固定相,以不同体积比的乙腈-含0.2%（体积分数）甲酸的5 mmol·L^-1乙酸铵溶液的混合液为流动相对其进行梯度洗脱。质谱分析采用电喷雾正、负离子源（ESI⁺、ESI^-）和多反应监测（MRM）模式,以基质匹配的混合标准溶液系列绘制工作曲线。结果显示：在大豆、茄子、甘蓝、西红柿、苹果、绿茶中,丁...     

超高效液相色谱-质谱/质谱联用法测定人血浆中的辛伐他汀

建立了超高效液相色谱-质谱/质谱联用法(UPLC-MS/MS)测定人血浆中辛伐他汀的浓度。血浆样品经乙醚-正己烷-异丙醇(体积比为80∶20∶3)提取,以洛伐他汀为内标,采用ACQUITY UPLCTM BEH C18柱(50 mm×2.1 mm,1.7 μm)分离,以乙腈-10 mmol/L乙酸铵水溶液(体积比为85∶15)为流动相,流速为0.25 mL/min,通过电喷雾离子化,采用多反应监测(MRM)方式进行正离子检测。线性范围为0.051～20.4 ng/mL,日内及日间测定的相对标准偏差不高于10%,平均回收率为91.6%。方法灵敏度高,分析速度快,操作简便,适用于辛伐他汀药物动力学和生物等效性研究。     

高速逆流色谱法分离纯化黄芪中的芒柄花素和毛蕊异黄酮

采用高速逆流色谱法(HSCCC),以正己烷-氯仿-甲醇-水组成二相系统作为固定相与流动相,对黄芪的乙酸乙酯粗提 物进行了分离纯化。 结果发现:以正己烷-氯仿-甲醇-水(体积比为1.5∶3∶3∶2)组成的系统可以从黄芪的乙酸乙酯粗 提物中分离出毛蕊异黄酮,纯度可达95％以上,并可以初步纯化芒柄花素;接着用正己烷-氯仿-甲醇-水(体积比为4∶4∶5 ∶4)组成的系统进一步纯化芒柄花素,其纯度达95％以上。利用该方法,可以对中药黄芪中的异黄酮进行快速的分离和纯 化。     

羟基封端聚丁二烯的临界点色谱定量方法研究

为建立混合物中羟基封端聚丁二烯（HTPB）的临界点色谱定量方法，以C18为固定相，考察了HTPB在四氢呋喃-乙腈和四氢呋喃-水两种流动相体系下的临界点色谱条件。结果表明，四氢呋喃-乙腈体积比为70.7：29.3以及四氢呋喃-水体积比为92：8时，HTPB的保留值与其相对分子质量无关。将该临界点色谱方法用于胶黏剂混合组分中HTPB的测定，结果表明，HTPB在46.7~216.4 mg/L范围内呈良好线性关系，相关系数（r）>0.99，检出限为4.2 mg/L。自配HTPB和矿物油双组分样品的加标回收率为89.2%~101.1%，相对标准偏差小于0.66%（n=6）。应用该方法对市售聚氨酯胶黏剂进行检测，测定结果为HTPB成分占26.6%。该方法快速、准确，能满足聚合物混合产品的生产质量控制和失效分析的要求。     

ESI／MS of N-（O, O-Diisopropyl） Phosphoryl Aromatic Amino Acids and their Stability Investigation Using HPLC／UV／ESI／MS

The full scan ESI/MS and ESI/MS^2 of N-(O, O-diisopropyl) phosphoryl aromatic amino acids (DIPPAAAs), N-(O, O-diisopropyl) phosphoryl phenylalanine, N-(O, O-diisopropyl)phosphoryl tryptophan and N-(O, O-diisopropyl) phosphoryl tyrosine, were obtained. The specific ions for them were found. Their stability in the LC mobile phase was investigated using developed HPLC/UV/ESI/MS and the results demonstrated that the DIPPAAAs were stable in the mobile phase (5 mmol/L NH4Ac-MeCN (80:20,v/v, pH7.5) within 48 h.     

高效液相色谱-四极杆/静电场轨道阱高分辨质谱法测定血清中胆固醇及其6种代谢标志物

利用高效液相色谱-四极杆/静电场轨道阱高分辨质谱（HPLC-Q/Orbitrap HRMS）测定血清中的胆固醇及其6种代谢标志物（2,4-脱氢胆甾醇、7-烯胆甾醇、菜油固醇、豆固醇、β-谷固醇和角鲨烯）。以乙腈作为提取溶剂,超声提取,采用Acquity UPLC BEH C₁₈色谱柱（100 mm×2.1 mm,1.7 μm）,以95%（v/v）的甲醇-乙腈（2：8,v/v）-5%（v/v）水做流动相,等度洗脱15 min,流速0.4 mL/min。在大气压化学电离源（APCI）正离子扫描模式下,质谱采用全扫描/数据依赖二级扫描（Full MS/dd MS²）监测模式,同时获得定性和定量结果,一级分辨率为70000 FWHM,二级分辨率为17500 FWHM。7种目标物质在其线性范围内的线性相关系数（r²）均不小于0.992,检出限为0.8~62.1 μg/L,3个加标水平下的回收率为82.1%~97.5%,相对标准偏差（RSD）为1.6%~7.4%。方法准确、简单、快捷,可以作为血清中胆固醇及其6种代谢标志物的检测方法。     

Fully automated method for the liquid chromatographic-tandem mass spectrometric determination of cyproterone acetate in human plasma using restricted access material for on-line sample clean-up

A new automated method for the quantitative analysis of cyproterone acetate (CPA) in human plasma has been developed using on-line solid phase extraction (SPE) prior to the LC-MS/MS determination. The method was based on the use of a pre-column packed with internal-surface reversed-phase material (LiChrospher RP-4 ADS, 25 mm x 2 mm) for sample clean-up coupled to LC separation on an octadecyl silica stationary phase by means of a column switching system. A 30 microl plasma sample volume was injected directly onto the pre-column using a mixture of water, acetonitrile and formic acid (90:10:0.1 (v/v/v)) adjusted to pH 4.0 with diluted ammonia as washing liquid. The analyte was then eluted in the back-flush mode with the LC mobile phase consisting of water, methanol and formic acid (10:90:0.1 (v/v/v)). The dispensing flow rates of the washing liquid and the LC mobile phase were 300 microl min(-1). Medroxyprogesterone acetate (MPA) was used as internal standard. The MS ionization of the analytes was achieved using electrospray (ESI) in the positive ion mode. The pseudomolecular ionic species of CPA and MPA (417.4 and 387.5) were selected to generate daughter ions at 357.4 and 327.5, respectively. Finally, the developed method was validated according to a new approach using accuracy profiles as a decision tool. Very good results with respect to accuracy, detectability, repeatability, intermediate precision and selectivity were obtained. The LOQ of cyproterone acetate was 300 pg ml(-1).     

Rapid-resolution liquid chromatography/mass spectrometry for determination and quantitation of polyphenols in grape berries

A rapid-resolution liquid chromatography/mass spectrometric (RRLC/MS) method for detection and quantitation of polyphenols in grape berry skins and seeds has been developed. Pulp-free berry skins were treated with liquid nitrogen and ground; seeds were also ground. Then, 3 g of samples were extracted with 30 mL of a mixture of methanol/water/formic acid 70:30:1 (v/v/v) under sonication and 1 microL of the final extract was injected into two 100 x 2.1 mm i.d., 1.8 microm Zorbax Eclipse plus C18 columns connected in series. Compounds were fractionated using a gradient elution of acidified acetonitrile/methanol 50:50 (v/v)/water. Columns were thermostatted at 70 degrees C. MS was carried out on an Agilent 6410 QqQ instrument equipped with an electrospray ionization source. Positive and negative MS/MS product ion scans were used for compound identification, whereas positive full scan MS in the m/z range 200-1400 was used for quantitation. By means of mass spectra comparison, various flavonols, flavan-3-ols, anthocyanins and stilbenes were identified. Quantitation was performed by external calibration, and concentration values were corrected for matrix effect that was evaluated in separate experiments. Semi-quantitative estimation was performed for compounds for which standards were not commercially available. Recoveries ranged from 90-102% with relative standard deviation (RSD) <5%, whereas the between samples RSD was in the range 4-12%. Two surrogate standards were used for quality control. The developed method was applied to analyze the polyphenol content of three Vitis vinifera table cultivars at physiological maturity and after proper preservation for 6 weeks. Results demonstrated that during preservation about half of the polyphenol content was lost.     

Optimization of chromatography to overcome matrix effect for reliable estimation of four small molecular drugs from biological fluids using LC–MS/MS

The article describes a systematic study to overcome the matrix effect during chromatographic analysis of gemfibrozil, rivastigmine, telmisartan and tacrolimus from biological fluids using LC–ESI–MS/MS. All four methods were thoroughly developed by the appropriate choice of analytical column, elution mode and pH of mobile phase for improved chromatography and overall method performance. Matrix effect was assessed by post-column analyte infusion, slope of calibration line approach and post-extraction spiking. The best chromatographic conditions established were: Acquity BEH C₁₈ (50 × 2.1 mm, 1.7 μm) column with 5.0 mm ammonium acetate, pH 6.0–methanol as the mobile phase under gradient program for gemfibrozil; Luna CN (50 × 2.0 mm, 3 μm) column with a mobile phase consisting of acetonitrile–10 mm ammonium acetate, pH 7.0 (90:10, v/v) for rivastigmine; Inertsustain C₁₈ (100 × 2.0 mm, 5 μm) column using methanol–2.0 mm ammonium formate, pH 5.5 (80: 20, v/v) as the mobile phase for isocratic elution of telmisartan; and Acquity BEH C₁₈ (50 × 2.1 mm, 1.7 μm) with methanol–10 mm ammonium acetate, pH 6.0 (95:5, v/v) as mobile phase for tacrolimus. The methods were thoroughly validated as per European Medicines Agency and US Food and Drug Administration guidance and were successfully applied for pharmacokinetic studies in healthy subjects.     

Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid-liquid extraction

Kaletra is an important antiretroviral drug, which has been developed by Abbott Laboratories. It is composed of lopinavir (low-pin-a-veer) and ritonavir (ri-toe-na-veer). Both have been proved to be human immunodeficiency virus (HIV) protease inhibitors and have substantially reduced the morbidity and mortality associated with HIV-1 infection. We have developed and validated an assay, using liquid chromatography coupled with atmospheric pressure chemical ionization tandem mass spectrometry (LC/MS/MS), for the routine quantification of lopinavir and ritonavir in human plasma, in which lopinavir and ritonavir can be simultaneously analyzed with high throughput. The sample preparation consisted of liquid-liquid extraction with a mixture of hexane: ethyl acetate (1:1, v/v), using 100 microL of plasma. Chromatographic separation was performed on a Waters Symmetry C(18) column (150 mm x 3.9 mm, particle size 5 microm) with reverse-phase isocratic using mobile phase of 70:30 (v/v) acetonitrile: 2 mM ammonium acetate aqueous solution containing 0.01% formic acid (v/v) at a flow rate of 1.0 mL/min. A Waters symmetry C(18) guard column (20 mm x 3.9 mm, particle size 5 microm) was connected prior to the analytical column, and a guard column back wash was performed to reduce the analytical column contamination using a mixture of tetrahydrofuran (THF), methanol and water (45:45:10, v/v/v). The analytical run was 4 min. The use of a 96-well plate autosampler allowed a batch size up to 73 study samples. A triple-quadrupole mass spectrometer was operated in a positive ion mode and multiple reaction monitoring (MRM) was used for drug quantification. The method was validated over the concentration ranges of 19-5,300 ng/mL for lopinavir and 11-3,100 ng/mL for ritonavir. A-86093 was used as an internal standard (I.S.). The relative standard deviation (RSD) were <6% for both lopinavir and ritonavir. Mean accuracies were between the designed limits (+/-15%). The robust and rapid LC/MS/MS assay has been successfully applied for routine assay to support bioavailability, bioequivalence, and pharmacokinetics studies.     

液相色谱-毛细管气相色谱/质谱离线联用分析烟草中的挥发性及半挥发性成分

建立了一种用于烟草样品中挥发性、半挥发性成分分析的液相色谱-毛细管气相色谱/质谱(LC-CGC/MS)离线联用方法。研究了LC-CGC/MS的分离机理。LC分析选用氨基分析柱(250 mm×2.0 mm, 5 μm)作为分析柱,正己烷-二氯甲烷-乙腈(90:6.6:3.4, v/v/v)作为流动相,对挥发性、半挥发性成分进行分离,收集得到5个馏分,并存放在5个氮吹瓶中。多次进样并收集相同时间段的馏分,氮吹浓缩至1 mL,然后分别进行CGC/MS分析,所用的CGC柱为DB-5MS(60 m×0.25 mm×0.25 μm)。结果显示,与直接采用CGC/MS分析相比,采用LC-CGC/MS分析复杂样本的效果更好,定性的可靠性更高。     

L-羟脯氨酸寡肽混合物的高效液相色谱分离与质谱分析

研究了三氯氧磷辅助下L-羟脯氨酸的成肽反应,建立了采用反相高效液相色谱-质谱/质谱联用技术分离鉴定羟脯氨酸寡肽混合物的方法,优化了L-羟脯氨酸寡肽混合物的色谱分离条件。实验以YWG C8柱(10 μm,250 mm×10 mm)为分离柱,以乙腈-0.06%三氟乙酸水溶液(体积比为2∶98)为流动相进行等度洗脱,在正离子模式下对洗脱物进行了电喷雾电离串联质谱鉴定。结果显示,分离出的各组分分别为L-羟脯氨酸二肽、L-羟脯氨酸环二肽和L-羟脯氨酸三肽。     

高效液相色谱-串联质谱法分离鉴定绿原酸及其相关杂质

建立了高效液相色谱-串联质谱法（HPLC-MS/MS)分离和鉴定绿原酸及其相关杂质的方法。采用C18色谱柱(5 μm,4.6 mm×150 mm),乙腈-水（含0.1%甲酸）(体积比为8∶92)为流动相,经HPLC-MS/MS和HPLC-二极管阵列检测器在线检测,对工业绿原酸中的奎尼酸、咖啡酸、绿原酸同分异构体等8个相关杂质的结构进行了鉴定。     

Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry

A sensitive and specific high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) assay for the quantitative determination of gemcitabine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU) is presented. A 200-microL aliquot of human plasma was spiked with a mixture of internal standards, didanosine, lamivudine and fludarabine, and extracted using solid-phase extraction. Dried extracts were reconstituted in 1 mM ammonium acetate/acetonitrile (97:3, v/v) and 10-microL volumes were injected onto the HPLC system. Separation was achieved on a 150 x 2.1 mm C18 bonded phase endcapped with polar groups (Synergi Hydro-RP column) using an eluent composed of 1 mM ammonium acetate (pH 6.8)/acetonitrile (94:6, v/v). Detection was performed by positive ion electrospray ionization followed by MS/MS. The assay quantifies a range from 0.5 to 1000 ng/mL for gemcitabine and from 5 to 10,000 ng/mL for dFdU using 200 microL of human plasma sample. Validation results demonstrate that gemcitabine and dFdU concentrations can be accurately and precisely quantified in human plasma. This assay is used to support clinical pharmacologic studies with gemcitabine.